Single Session Intervention to Promote Hope

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to develop a brief, self-guided single-session intervention (SSI) that targets the development of, or increase in, hope, and pilot test it for the primary outcomes of feasibility, acceptability/likeability, safety, and changes in hope, and the secondary outcomes of self-worth, empowerment, and emotional wellbeing among women experiencing intimate partner violence (IPV). The study will be conducted in 2 stages: intervention development (Intervention Development Stage), and pilot testing the intervention (Pilot Stage). The focus of this registration is the Pilot Stage.

Clinical Trial Description

This study aims to accomplish two primary objectives: Objective 1 (Intervention Development Stage): Develop a brief, self-guided SSI to enhance hope and in turn, self-worth, empowerment, and emotional wellbeing, and Objective 2 (Pilot Stage): Pilot test the intervention and evaluate the process of implementation and primary outcomes of feasibility, acceptability/likability, and safety; and to assess changes in hope and secondary outcomes of self-worth, empowerment, and emotional wellbeing. The Pilot Stage will utilize micro-longitudinal methods (i.e., daily self-reports of hope, self-worth, empowerment, and emotional wellbeing for 14 days before and after the intervention) to assess changes in these constructs. Eligible participants will take part in a baseline interview with a member of the research team. Baseline measures will be based on participant self-report and used to characterize the sample and collect data on person-level control variables. Beginning the day after the baseline interview, participants will complete a brief daily survey on their smartphone. On day 15, participants will receive a link to the SSI and be asked to complete it that day; immediately following the SSI, participants will be asked to complete the post-intervention survey/process supplement to aid in the process evaluation. After completion of the SSI, survivors will participate in 14 additional days of daily data collection to establish post-intervention outcome measures. ;

Study Design

Related Conditions & MeSH terms

Domestic Violence

Clinical Trial Details

NCT number	NCT06375876
Study type	Interventional
Source	Yale University
Contact	Tami Sullivan, PhD
Phone	203-789-7645
Email	tami.sullivan@yale.edu
Status	Not yet recruiting
Phase	N/A
Start date	April 2024
Completion date	April 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03037749` - Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence	N/A
Completed	`NCT02606344` - Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV	N/A
Completed	`NCT03482687` - It's Your Game: An Innovative Approach to Preventing Teen Dating Violence	N/A
Active, not recruiting	`NCT00847548` - Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting	N/A
Completed	`NCT01207258` - Brief Intervention for Problem Drinking and Partner Violence	Phase 2
Completed	`NCT00983593` - A Randomized Clinical Study of a Mind-Body Approach to Domestic Violence Offender Treatment	N/A
Completed	`NCT01621334` - The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use	Phase 1
Completed	`NCT01803932` - Evaluation of a Male-focused Intervention to Prevent Intimate Partner Violence in a Conflict-affected Setting	N/A
Completed	`NCT00289939` - Reducing HIV & Domestic Violence Risk in Women Offenders	Phase 3
Completed	`NCT05598697` - Economic Evaluation of the MEWE Intervention	N/A
Not yet recruiting	`NCT03672942` - Communication Skills vs. Mindfulness for IPV	N/A
Completed	`NCT03883932` - Fatherhood Focused Family Violence Education Program	N/A
Completed	`NCT05129501` - The Impact of an Adapted Version of the Strengthening Families Program on IPV Among Caregivers and ACEs Among Children	N/A
Enrolling by invitation	`NCT05139069` - Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women	N/A
Recruiting	`NCT03198429` - Cluster RCT of Embedded Parenting Intervention to Prevent Recurrence and Reduce Impairment in Young Children Exposed to Domestic Violence	N/A
Completed	`NCT04125251` - Men Engagement in Women Empowerment for Improving Maternal Mental Health Through Cash Transfer and Life Skills Building	N/A
Active, not recruiting	`NCT03236948` - RCT of the Effectiveness of the WfWI Intervention in Afghanistan	Phase 3
Completed	`NCT02258841` - Effectiveness of an Online Safety Tool for Canadian Women Experiencing Intimate Partner Violence	N/A
Completed	`NCT01958554` - Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence	Phase 2
Completed	`NCT01688427` - Perinatal Nurse Home Visiting Enhanced With mHealth Technology	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.